KRAS and colorectal carcinoma: KRAS-positive CRC tissues compared to negative counterparts were found to be involved in 46 biological signaling pathways (Supplementary Image 3), and all the significantly deregulated pathways with DEGs involved in are listed in Supplementary Table 4.